97 related articles for article (PubMed ID: 27572702)
1. Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression.
Zhang X; Fan Y; Liu B; Qi X; Guo Z; Li L
Breast Cancer; 2017 May; 24(3):433-441. PubMed ID: 27572702
[TBL] [Abstract][Full Text] [Related]
2. CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB.
Kumar R; Cheney KM; McKirdy R; Neilsen PM; Schulz RB; Lee J; Cohen J; Booker GW; Callen DF
J Biol Chem; 2008 Jul; 283(27):19026-38. PubMed ID: 18456661
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro.
Li LH; He J; Hua D; Guo ZJ; Gao Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):207-15. PubMed ID: 20890603
[TBL] [Abstract][Full Text] [Related]
4. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
Zhang X; Gao D; Fang K; Guo Z; Li L
Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
[TBL] [Abstract][Full Text] [Related]
5. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
6. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
7. Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells.
Cui X; Xu D; Lv C; Qu F; He J; Chen M; Liu Y; Gao Y; Che J; Yao Y; Yu H
BMB Rep; 2011 Aug; 44(8):547-52. PubMed ID: 21871180
[TBL] [Abstract][Full Text] [Related]
8. Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.
Liu B; Qi X; Zhang X; Gao D; Fang K; Guo Z; Li L
J Cell Biochem; 2019 Jan; 120(1):507-518. PubMed ID: 30161287
[TBL] [Abstract][Full Text] [Related]
9. MED19 promotes proliferation and tumorigenesis of lung cancer.
Sun M; Jiang R; Li JD; Luo SL; Gao HW; Jin CY; Shi DL; Wang CG; Wang B; Zhang XY
Mol Cell Biochem; 2011 Sep; 355(1-2):27-33. PubMed ID: 21519921
[TBL] [Abstract][Full Text] [Related]
10. CXCL11 negatively regulated by MED19 favours antitumour immune infiltration in breast cancer.
Zhang X; Wu J; Hu C; Zheng X; Guo Z; Li L
Cytokine; 2023 Feb; 162():156106. PubMed ID: 36512935
[TBL] [Abstract][Full Text] [Related]
11. Med19 promotes gastric cancer progression and cellular growth.
Ding XF; Huang GM; Shi Y; Li JA; Fang XD
Gene; 2012 Aug; 504(2):262-7. PubMed ID: 22565189
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of MED19 by short hairpin RNA-mediated gene silencing inhibits pancreatic cancer cell proliferation.
Li XH; Fang DN; Zeng CM
Cancer Biother Radiopharm; 2011 Aug; 26(4):495-501. PubMed ID: 21834715
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.
Liu Y; Tao X; Fan L; Jia L; Gu C; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1050-6. PubMed ID: 22961438
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
[TBL] [Abstract][Full Text] [Related]
15. Disruption of mediator complex subunit 19 (Med19) inhibits cell growth and migration in tongue cancer.
Zhu LJ; Yan WX; Chen ZW; Chen Y; Chen D; Zhang TH; Liao GQ
World J Surg Oncol; 2013 May; 11():116. PubMed ID: 23705783
[TBL] [Abstract][Full Text] [Related]
16. The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells.
Zou SW; Ai KX; Wang ZG; Yuan Z; Yan J; Zheng Q
Acta Pharmacol Sin; 2011 Mar; 32(3):354-60. PubMed ID: 21372827
[TBL] [Abstract][Full Text] [Related]
17. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.
Kumar R; Manning J; Spendlove HE; Kremmidiotis G; McKirdy R; Lee J; Millband DN; Cheney KM; Stampfer MR; Dwivedi PP; Morris HA; Callen DF
Mol Cancer Res; 2006 Sep; 4(9):655-65. PubMed ID: 16966434
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase.
Wang T; Hao L; Feng Y; Wang G; Qin D; Gu G
Oncol Res; 2011; 19(5):193-201. PubMed ID: 21542455
[TBL] [Abstract][Full Text] [Related]
19. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
[TBL] [Abstract][Full Text] [Related]
20. Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.
Hartman J; Lam EW; Gustafsson JA; Ström A
Breast Cancer Res; 2009; 11(6):R79. PubMed ID: 19891787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
